Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
COGNITION THERAPEUTICS INC | Chief Financial Officer | Common Stock | 121K | $236K | $1.95 | May 1, 2024 | Direct |
COGNITION THERAPEUTICS INC | Chief Financial Officer | Stock Option (Right to Buy) | 20K | Feb 15, 2024 | Direct | ||
CHIASMA, INC | Chief Financial Officer | Stock Option (Right to Buy) | 0 | Aug 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CGTX | COGNITION THERAPEUTICS INC | May 1, 2024 | 1 | -$17K | 4 | May 3, 2024 | Chief Financial Officer |
CGTX | COGNITION THERAPEUTICS INC | Feb 15, 2024 | 2 | $0 | 4 | Feb 20, 2024 | Chief Financial Officer |
CGTX | COGNITION THERAPEUTICS INC | May 1, 2023 | 2 | $0 | 4 | May 3, 2023 | Chief Financial Officer |
CGTX | COGNITION THERAPEUTICS INC | May 1, 2023 | 0 | $0 | 3 | May 3, 2023 | Chief Financial Officer |
CHMA | CHIASMA, INC | Aug 5, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Chief Financial Officer |